Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
acetylsalicylic acid (aspirin) (1 trial)
dalcetrapib (3 trials)
rivaroxaban (xarelto) (1 trial)
avenanthramides (1 trial)
etripamil (1 trial)
zirconium silicate (Lokelma) (1 trial)
Acute Coronary Syndrome (Phase 3)
Atrial Fibrillation (Phase 3)
Heart Failure (Phase 2)
Syndrome (Phase 3)
Trials (7 total)
Trial APIs (6 total)